About Druggability Technologies

About company

Druggability Technologies (DRGT) is a specialty pharmaceutical company dedicated to the development and commercialization of high-value proprietary drugs that deliver measurable and meaningful improvement in clinical utility. This mission is enabled through the deployment of the Company's Super-API drug development platform. Utilizing its Super-API platform the Company carefully selects and screens drugs and develops their Super-API compositions. The Super-API compositions are protected by global composition of matter IPs.